EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access

Fibrosis Entropy Is Associated With Life‐Threatening Arrhythmia in Nonischemic Cardiomyopathy

Daniel J Hammersley iD, Hassan A Zaidi iD, Richard E Jones iD, Suzan Hatipoglu iD, Emmanuel Androulakis, Gabriel Balaban iD, Lukas Mach, Amrit S Lota iD, Zohya Khalique iD, Antonio De Marvao iD, Aleksandra Lopuszko iD, Laura Lazzari und 13 weitere

Journal of the American Heart Association · 2025

DOI: 10.1161/jaha.124.040517 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Journal of the American Heart Association, 2025. Verfasst von Daniel J Hammersley und 24 weiteren Autor:innen. Beteiligte Einrichtung: King's College Hospital NHS Foundation Trust London United Kingdom. Hauptthemen laut MEDLINE: Cardiomyopathies, Arrhythmias, Cardiac, Myocardium. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Wellcome Trust.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Greater precision is required for arrhythmic risk stratification of patients with nonischemic cardiomyopathy (NICM). We sought to evaluate whether fibrosis entropy, a measure of scar texture heterogeneity derived from late gadolinium enhancement cardiovascular magnetic resonance, has incremental utility to fibrosis presence for arrhythmic risk prediction in NICM.

Methods

In this prospective observational cohort study, fibrosis entropy was calculated for patients with NICM and fibrosis (late gadolinium enhancement positive, LGE+), including regions of core fibrosis, gray zone fibrosis and combined core and gray zone fibrosis. Patients with NICM and no fibrosis (LGE‐) were included as a comparator group. Adjudicated follow‐up for life‐threatening arrhythmia included sudden cardiac death, aborted sudden cardiac death, or sustained ventricular tachycardia.

Results

Of 291 patients with LGE+ NICM, 38 (13.1%) experienced life‐threatening arrhythmia over a median follow‐up of 6.3 years. Core fibrosis entropy (per‐SD hazard ratio [HR], 1.77 [95% CI, 1.25–2.52]; P =0.001), gray zone fibrosis entropy (HR, 1.97 [95% CI, 1.20–2.54]; P =0.004), and combined fibrosis entropy (HR, 1.98 [95% CI, 1.30–3.02]; P =0.004) were each associated with life‐threatening arrhythmia after adjustment for variables used to determine implantable cardioverter‐defibrillator candidacy in clinical practice (left ventricular ejection fraction ≤35% and New York Heart Association class >1) and remained associated after accounting for core and gray zone fibrosis mass. Left ventricular ejection fraction ≤35% was not associated with life‐threatening arrhythmia (HR, 1.45 [95% CI, 0.77–2.74]; P =0.250). Integration of fibrosis presence with fibrosis entropy classified patients into low‐, intermediate‐, and high‐arrhythmic‐risk groups.

Conclusions

Deeper phenotypic characterization of scar using fibrosis entropy offers incremental utility to left ventricular ejection fraction and fibrosis presence for arrhythmic risk stratification in NICM.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CardiomyopathiesArrhythmias, CardiacMyocardiumHumansMaleFemaleMiddle AgedFibrosisProspective StudiesAgedRisk AssessmentMagnetic Resonance Imaging, CineEntropyRisk Factors

Stichwörter der Autor:innen

arrhythmic risk stratificationentropyfibrosisnonischemic cardiomyopathy

Autor:innen und Institutionen

  • King's College Hospital NHS Foundation Trust London United Kingdom.
  • British Heart Foundation Centre of Research Excellence, School of Cardiovascular and Metabolic Medicine and Sciences King's College London London United Kingdom.
  • Royal Brompton & Harefield Hospital Guy's & St Thomas' NHS Trust London United Kingdom.
  • National Heart and Lung Institute Imperial College London London United Kingdom.
  • Department of Biomedical Engineering King's College London London United Kingdom.
  • Essex Cardiothoracic Centre Basildon United Kingdom.

ORCID-Profile: Daniel J Hammersley, Hassan A Zaidi, Richard E Jones, Suzan Hatipoglu, Gabriel Balaban, Amrit S Lota, Zohya Khalique, Antonio De Marvao, Aleksandra Lopuszko, Upasana Tayal, Francisco Leyva, A John Baksi, James S Ware, Pablo Lamata, Dudley J Pennell, Brian P Halliday, Sanjay K Prasad

Förderung

  • Wellcome Trust

Zitieren

APA

Hammersley, D. J., Zaidi, H. A., Jones, R. E., Hatipoglu, S., Androulakis, E., Balaban, G., Mach, L., Lota, A. S., Khalique, Z., De Marvao, A., Lopuszko, A., Lazzari, L., Ravendren, A., Gulati, A., Baruah, R., Guha, K., Tayal, U., Leyva, F., Baksi, A. J., …, & Prasad, S. K. (2025). Fibrosis Entropy Is Associated With Life‐Threatening Arrhythmia in Nonischemic Cardiomyopathy. Journal of the American Heart Association. https://doi.org/10.1161/jaha.124.040517

Vancouver

Hammersley DJ, Zaidi HA, Jones RE, Hatipoglu S, Androulakis E, Balaban G, et al. Fibrosis Entropy Is Associated With Life‐Threatening Arrhythmia in Nonischemic Cardiomyopathy. Journal of the American Heart Association. 2025. doi:10.1161/jaha.124.040517

BibTeX
@article{Hammersley2025,
  author = {Hammersley, Daniel J and Zaidi, Hassan A and Jones, Richard E and Hatipoglu, Suzan and Androulakis, Emmanuel and Balaban, Gabriel and Mach, Lukas and Lota, Amrit S and Khalique, Zohya and De Marvao, Antonio and Lopuszko, Aleksandra and Lazzari, Laura and Ravendren, Andrew and Gulati, Ankur and Baruah, Resham and Guha, Kaushik and Tayal, Upasana and Leyva, Francisco and Baksi, A John and Ware, James S and Lamata, Pablo and Pennell, Dudley J and Halliday, Brian P and Bishop, Martin J and Prasad, Sanjay K},
  title = {Fibrosis Entropy Is Associated With Life‐Threatening Arrhythmia in Nonischemic Cardiomyopathy},
  journal = {Journal of the American Heart Association},
  year = {2025},
  doi = {10.1161/jaha.124.040517}
}
Kostenlos starten →